Episealer® (knee) to be presented at Polish orthopaedic congress

Episurf Medical (Nasdaq: EPIS B) today announces that the Episealer® Knee technology will be presented at a Polish orthopaedic congress (STAW RZEPKOWO-UDOWY Od diagnostyki do protezoplastyki), arranged by the Department of Orthopaedics, Clinic of Orthopaedics and Traumatology at the Medical University of Lublin on May 27, as part of the scientific program. The presentation “New solution for osteochondral defects” is held by Dr Tobias Jung, from Charité Universitätsmedizin in Berlin, Germany, and focuses on surgical technology and clinical results from the use of the Episealer® Knee implant.

“We recently entered the Polish market and we are pleased to have such a renowned surgeon as Dr Tobias Jung presenting at this important congress”, says Pål Ryfors, CEO Episurf Medical.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

Tags: